NASDAQ: BLCMBellicum Pharmaceuticals Inc Stock Ownership - Who owns Bellicum Pharmaceuticals?
Insider buying vs selling
Have Bellicum Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when BLCM insiders and whales buy or sell their stock.
BLCM Shareholders
What type of owners hold Bellicum Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frank B. McGuyer | 23.33% | 2,215,398 | $1.68M | Insider |
| Mcguyer Investments Ltd | 23.33% | 2,215,398 | $1.68M | Insider |
| Remeditex Ventures LLC | 19.03% | 1,807,603 | $1.37M | Insider |
| James F. Brown | 9.83% | 933,706 | $709.62k | Insider |
| Kevin M. Slawin | 9.40% | 892,453 | $678.26k | Insider |
| Ikarian Capital LLC | 4.72% | 448,101 | $340.56k | Institution |
| Long Focus Capital Management LLC | 3.45% | 327,692 | $249.05k | Institution |
| Baker Bros Advisors LP | 3.13% | 297,675 | $226.23k | Insider |
| Baker Bros Advisors LP | 2.62% | 249,123 | $189.33k | Institution |
| Jon P. Stonehouse | 2.15% | 204,086 | $155.11k | Insider |
BLCM vs Biotech Stocks
Bellicum Pharmaceuticals Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.